Citadel Advisors’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-160,264
| Closed | -$24K | – | 5388 |
|
|
2019
Q3 | $24K | Buy |
160,264
+145,624
| +995% | +$21.8K | ﹤0.01% | 4483 |
|
|
2019
Q2 | $2K | Sell |
14,640
-51,671
| -78% | -$7.06K | ﹤0.01% | 4592 |
|
|
2019
Q1 | $13K | Buy |
66,311
+50,537
| +320% | +$9.91K | ﹤0.01% | 4449 |
|
|
2018
Q4 | $11K | Sell |
15,774
-1,022
| -6% | -$713 | ﹤0.01% | 4401 |
|
|
2018
Q3 | $21K | Buy |
+16,796
| New | +$21K | ﹤0.01% | 4131 |
|
|
2018
Q2 | – | Sell |
-12,021
| Closed | -$24K | – | 4773 |
|
|
2018
Q1 | $24K | Sell |
12,021
-16,069
| -57% | -$32.1K | ﹤0.01% | 3851 |
|
|
2017
Q4 | $34K | Buy |
28,090
+10,752
| +62% | +$13K | ﹤0.01% | 3707 |
|
|
2017
Q3 | $22K | Buy |
+17,338
| New | +$22K | ﹤0.01% | 3507 |
|
|
2017
Q2 | – | Sell |
-22,676
| Closed | -$42K | – | 4398 |
|
|
2017
Q1 | $42K | Sell |
22,676
-5,405
| -19% | -$10K | ﹤0.01% | 3431 |
|
|
2016
Q4 | $145K | Buy |
+28,081
| New | +$145K | ﹤0.01% | 3172 |
|